Ind-Swift Laboratories Ltd
₹142.38
as on
Ind-Swift Laboratories Stock Performance
as on April 22, 2026 at 9:31 pm IST
Day's Low
Day's High
₹141.96₹146.49
0.29%
Downside
2.89%
Upside
52 Week's Low
52 Week's High
₹68.72₹156.8051.73%
Downside
10.13%
Upside
Ind-Swift Laboratories share price movements today
- Previous Close
- ₹143.94
- Open
- ₹144.00
- Volume
- 6.22L
- Upper Circuit
- ₹172.72
- Lower Circuit
- ₹115.16
- Day's Low - High
- ₹141.96 - ₹146.49
- 52 Week Low - High
- ₹68.72 - ₹156.80
Ind-Swift Laboratories Historical Returns
- 1 Month Return
- + 7.39 %
- 3 Month Return
- + 34.71 %
- 1 Year Return
- + 69.4 %
- 3 Year Return
- + 118.09 %
- 5 Year Return
- + 83.48 %
Ind-Swift Laboratories Fundamentals
as on April 22, 2026 at 4:01 pm IST
Market Cap
₹1,249.93 Cr
Return on Equity (ROE)
0.64
PE Ratio (TTM)
3.95
Return on capital employed (ROCE)
1.09
Industry PE ratio
42.01
Beta (LTM)
1.13
P/B Ratio
0.53
Dividend Yield
0PEG Ratio
-0.08
Quarterly Earnings Growth YOY
-273.09
EPS (TTM)
36.44
Sector
Pharmaceuticals
Book Value
159.86
Technical Analysis
Bullish
View Technical Analysis
Ind-Swift Laboratories Stock Valuation
as on April 22, 2026 at 4:01 pm IST
Ind-Swift Laboratories in the last 5 years
Lowest (-1795.00x)
December 8, 2022
Today (3.95x)
April 21, 2026
Industry (42.01x)
April 21, 2026
Highest (64.97x)
July 19, 2021
Today’s Price to Earnings Ratio: 3.95x
Ind-Swift Laboratories Ltd vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Ind-Swift Laboratories with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 1,249.93 | 16.7% | 0.52 | 250 | 561 | |
| NA | 1,395.44 | 4.16% | 0.61 | 21 | 368 | |
| NA | 6.72 | -1.94% | 0.00 | -2 | 13 | |
| BUY | 8,010.58 | 30.76% | 0.56 | 382 | 2,622 | |
| NA | 236.42 | -10.67% | 0.69 | -114 | 1,669 |
Ind-Swift Laboratories Stock’s Investor Sentiment and Interest
Search interest for Ind-Swift Laboratories Ltd Stock has increased by 8% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:8% versus previous 30 day period
Ind-Swift Laboratories Ltd Quarterly Profit & Loss
Figures in Rupees Crores
Ind-Swift Laboratories Ltd Annual Profit & Loss
Figures in Rupees Crores
Ind-Swift Laboratories Ltd Cash Flow
Figures in Rupees Crores
Ind-Swift Laboratories Corporate Actions
View detailed summary of the earnings and dividend history of Ind-Swift Laboratories.
Ind-Swift Laboratories Ltd Earnings Results
Ind-Swift Laboratories Ltd’s net profit jumped 273.77% since last year same period to ₹9.54Cr in the Q3 2025-2026. On a quarterly growth basis, Ind-Swift Laboratories Ltd has generated 19.4% jump in its net profits since last 3-months.
Read More about Earnings ResultsInd-Swift Laboratories Ltd Dividends May,2011
In the quarter ending March 2011, Ind-Swift Laboratories Ltd has declared dividend of ₹1.00 per share on 25 May 2011 - translating a dividend yield of 1.39%.
Read More about Dividends
Insights on Ind-Swift Laboratories Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPromoter Holding Up
Promoters have increased holdings from 39.50% to 43.06% in Feb 2026 quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, 7.99 Cr → 9.54 Cr (in ₹), with an average increase of 16.3% per quarter
- POSITIVE IMPACT
Best in 1 Year
In the last 1 year, INDSWFTLAB has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 167.32 Cr → 178.43 Cr (in ₹), with an average increase of 3.2% per quarter
- POSITIVE IMPACT
Price Rise
In the last 3 months, INDSWFTLAB stock has moved up by 34.7%
NO EFFECTAgainst Peers
In the last 3 years, Lupin Ltd has given 229.3% return, outperforming this stock by 111.2%
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 45.50% to 42.98% in Feb 2026 quarter
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 14.33% to 13.80% in Feb 2026 quarter
About Ind-Swift Laboratories Ltd
Revenue: ₹150.85Cr as on December 2025 (Q3 FY26)
Net Profit: ₹9.52Cr as on December 2025 (Q3 FY26)
Listing date: 02 Jul, 1997
Chairperson Name: N R Munjal
| Organisation | Ind-Swift Laboratories Ltd |
| Headquarters | Chandigarh |
| Industry | Pharmaceuticals |
| CEO | N R Munjal |
| E-voting on shares | Click here to vote |
FAQs
What is Ind-Swift Laboratories share price today?
Ind-Swift Laboratories share price today stands at ₹142.38 as on at the close of the market. Ind-Swift Laboratories share today touched a day high of ₹146.49 and a low of ₹141.96.
What is the 52 week high and 52 week low range for Ind-Swift Laboratories share?
Ind-Swift Laboratories touched a 52 week high of ₹156.8 and a 52 week low of ₹68.72. Ind-Swift Laboratories share price today i.e. is closed at ₹142.38, which is -9.20% down from its 52 week high and 107.19% up from its 52 week low.
What is Ind-Swift Laboratories's market capitalisation today?
Ind-Swift Laboratories market capitalisation is ₹1,249.93 Cr as on .
How to buy Ind-Swift Laboratories shares?
To buy Ind-Swift Laboratories shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for INDSWFTLAB or Ind-Swift Laboratories Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Ind-Swift Laboratories shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is Ind-Swift Laboratories trading volume today?
Ind-Swift Laboratories trading volume is 6.22L as on . This means that 6.22L shares of Ind-Swift Laboratories were bought and sold on the stock market during today's trading session.